Cargando…

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

BACKGROUND: To address human resource and infrastructure shortages, resource-constrained countries are being encouraged to shift HIV care to lesser trained care providers and lower level health care facilities. This study evaluated the cost-effectiveness of down-referring stable antiretroviral thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Lawrence, Brennan, Alana, Fox, Matthew P., Ndibongo, Buyiswa, Jaffray, Imogen, Sanne, Ian, Rosen, Sydney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139666/
https://www.ncbi.nlm.nih.gov/pubmed/21811402
http://dx.doi.org/10.1371/journal.pmed.1001055
_version_ 1782208489573056512
author Long, Lawrence
Brennan, Alana
Fox, Matthew P.
Ndibongo, Buyiswa
Jaffray, Imogen
Sanne, Ian
Rosen, Sydney
author_facet Long, Lawrence
Brennan, Alana
Fox, Matthew P.
Ndibongo, Buyiswa
Jaffray, Imogen
Sanne, Ian
Rosen, Sydney
author_sort Long, Lawrence
collection PubMed
description BACKGROUND: To address human resource and infrastructure shortages, resource-constrained countries are being encouraged to shift HIV care to lesser trained care providers and lower level health care facilities. This study evaluated the cost-effectiveness of down-referring stable antiretroviral therapy (ART) patients from a doctor-managed, hospital-based ART clinic to a nurse-managed primary health care facility in Johannesburg, South Africa. METHODS AND FINDINGS: Criteria for down-referral were stable ART (≥11 mo), undetectable viral load within the previous 10 mo, CD4>200 cells/mm(3), <5% weight loss over the last three visits, and no opportunistic infections. All patients down-referred from the treatment-initiation site to the down-referral site between 1 February 2008 and 1 January 2009 were compared to a matched sample of patients eligible for down-referral but not down-referred. Outcomes were assigned based on vital and health status 12 mo after down-referral eligibility and the average cost per outcome estimated from patient medical record data. The down-referral site (n = 712) experienced less death and loss to follow up than the treatment-initiation site (n = 2,136) (1.7% versus 6.2%, relative risk = 0.27, 95% CI 0.15–0.49). The average cost per patient-year for those in care and responding at 12 mo was US$492 for down-referred patients and US$551 for patients remaining at the treatment-initiation site (p<0.0001), a savings of 11%. Down-referral was the cost-effective strategy for eligible patients. CONCLUSIONS: Twelve-month outcomes of stable ART patients who are down-referred to a primary health clinic are as good as, or better than, the outcomes of similar patients who are maintained at a hospital-based ART clinic. The cost of treatment with down-referral is lower across all outcomes and would save 11% for patients who remain in care and respond to treatment. These results suggest that this strategy would increase treatment capacity and conserve resources without compromising patient outcomes. Please see later in the article for the Editors' Summary
format Online
Article
Text
id pubmed-3139666
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31396662011-08-02 Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort Long, Lawrence Brennan, Alana Fox, Matthew P. Ndibongo, Buyiswa Jaffray, Imogen Sanne, Ian Rosen, Sydney PLoS Med Research Article BACKGROUND: To address human resource and infrastructure shortages, resource-constrained countries are being encouraged to shift HIV care to lesser trained care providers and lower level health care facilities. This study evaluated the cost-effectiveness of down-referring stable antiretroviral therapy (ART) patients from a doctor-managed, hospital-based ART clinic to a nurse-managed primary health care facility in Johannesburg, South Africa. METHODS AND FINDINGS: Criteria for down-referral were stable ART (≥11 mo), undetectable viral load within the previous 10 mo, CD4>200 cells/mm(3), <5% weight loss over the last three visits, and no opportunistic infections. All patients down-referred from the treatment-initiation site to the down-referral site between 1 February 2008 and 1 January 2009 were compared to a matched sample of patients eligible for down-referral but not down-referred. Outcomes were assigned based on vital and health status 12 mo after down-referral eligibility and the average cost per outcome estimated from patient medical record data. The down-referral site (n = 712) experienced less death and loss to follow up than the treatment-initiation site (n = 2,136) (1.7% versus 6.2%, relative risk = 0.27, 95% CI 0.15–0.49). The average cost per patient-year for those in care and responding at 12 mo was US$492 for down-referred patients and US$551 for patients remaining at the treatment-initiation site (p<0.0001), a savings of 11%. Down-referral was the cost-effective strategy for eligible patients. CONCLUSIONS: Twelve-month outcomes of stable ART patients who are down-referred to a primary health clinic are as good as, or better than, the outcomes of similar patients who are maintained at a hospital-based ART clinic. The cost of treatment with down-referral is lower across all outcomes and would save 11% for patients who remain in care and respond to treatment. These results suggest that this strategy would increase treatment capacity and conserve resources without compromising patient outcomes. Please see later in the article for the Editors' Summary Public Library of Science 2011-07-19 /pmc/articles/PMC3139666/ /pubmed/21811402 http://dx.doi.org/10.1371/journal.pmed.1001055 Text en Long et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Long, Lawrence
Brennan, Alana
Fox, Matthew P.
Ndibongo, Buyiswa
Jaffray, Imogen
Sanne, Ian
Rosen, Sydney
Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title_full Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title_fullStr Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title_full_unstemmed Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title_short Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
title_sort treatment outcomes and cost-effectiveness of shifting management of stable art patients to nurses in south africa: an observational cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139666/
https://www.ncbi.nlm.nih.gov/pubmed/21811402
http://dx.doi.org/10.1371/journal.pmed.1001055
work_keys_str_mv AT longlawrence treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT brennanalana treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT foxmatthewp treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT ndibongobuyiswa treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT jaffrayimogen treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT sanneian treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort
AT rosensydney treatmentoutcomesandcosteffectivenessofshiftingmanagementofstableartpatientstonursesinsouthafricaanobservationalcohort